Picture of Cordlife logo

P8A Cordlife Cashflow Statement

0.000.00%
sg flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Annual cashflow statement for Cordlife, fiscal year end - December 31st, SGD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line7.015.54.26-19-11
Depreciation
Amortisation
Non-Cash Items-0.952-3.12-4.02-2.94-1.16
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-0.128-0.1245.536.47.84
Change in Accounts Receivable
Change in Inventories
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities9.55.949.8-11.30.044
Capital Expenditures-1.57-2.4-2.83-3.4-1.46
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-22.36.830.21.58.17
Sale of Fixed Assets
Change in Net Investments
Other Investing Cash Flow
Cash from Investing Activities-23.94.43-2.63-1.96.71
Financing Cash Flow Items9.65-9.37-0.2688.36-0.152
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities3.37-11.7-1.866.26-2.26
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-10.5-2.085.04-6.933.7